193 related articles for article (PubMed ID: 36056642)
1. High density of CD8 T cell and immune imbalance of T lymphocytes subsets are associated with proliferative verrucous leukoplakia.
Fernandes D; Barbeiro CO; Palaçon MP; Biancardi MR; Ferrisse TM; Silveira HA; Castilho RM; de Almeida LY; Leon JE; Bufalino A
Immunology; 2023 Jan; 168(1):96-109. PubMed ID: 36056642
[TBL] [Abstract][Full Text] [Related]
2. Identification of Proteomic Biomarkers in Proliferative Verrucous Leukoplakia through Liquid Chromatography With Tandem Mass Spectrometry.
Arroyo E; Pérez Sayáns M; Bravo SB; de Oliveira Barbeiro C; Paravani Palaçon M; Chamorro Petronacci CM; García Vence M; Chantada Vázquez MDP; Blanco Carrión A; Suárez Peñaranda JM; García García A; Gándara Vila P; Días Almeida J; Veríssimo da Costa GC; Sousa Nogueira FC; Medeiros Evaristo JA; de Abreu Pereira D; Rintala M; Salo T; Rautava J; Padín Iruegas E; Oliveira Alves MG; Morandin Ferrisse T; Albergoni da Silveira H; Esquiche León J; Vilela Silva E; Flores IL; Bufalino A
Lab Invest; 2023 Oct; 103(10):100222. PubMed ID: 37507024
[TBL] [Abstract][Full Text] [Related]
3. [Proliferative verrucous leukoplakia. Report of five cases].
Reichart PA; Philipsen HP
Mund Kiefer Gesichtschir; 2003 May; 7(3):164-70. PubMed ID: 12764683
[TBL] [Abstract][Full Text] [Related]
4. Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens.
Palaçon MP; de Oliveira Barbeiro C; Fernandes D; Biancardi MR; Silveira HA; Ferrisse TM; León JE; Kujan O; Bufalino A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982316
[TBL] [Abstract][Full Text] [Related]
5. Clinical, histopathological characteristics and malignant transformation of proliferative verrucous leukoplakia with 36 patients: a retrospective longitudinal study.
Zhang C; Lan Q; Wei P; Gao Y; Zhang J; Hua H
BMC Oral Health; 2024 May; 24(1):639. PubMed ID: 38816724
[TBL] [Abstract][Full Text] [Related]
6. Proliferative verrucous leukoplakia and field cancerization: report of a case.
Feller L; Wood NH; Raubenheimer EJ
J Int Acad Periodontol; 2006 Apr; 8(2):67-70. PubMed ID: 16623182
[TBL] [Abstract][Full Text] [Related]
7. Predictors of malignant transformation in oral leukoplakia and proliferative verrucous leukoplakia: An observational prospective study including the DNA ploidy status.
Pentenero M; Castagnola P; Castillo FV; Isaevska E; Sutera S; Gandolfo S
Head Neck; 2023 Oct; 45(10):2589-2604. PubMed ID: 37563936
[TBL] [Abstract][Full Text] [Related]
8. Potentially malignant disorders revisited-The lichenoid lesion/proliferative verrucous leukoplakia conundrum.
Thomson PJ; Goodson ML; Smith DR
J Oral Pathol Med; 2018 Jul; 47(6):557-565. PubMed ID: 29663518
[TBL] [Abstract][Full Text] [Related]
9. Expanded Expression of Toll-Like Receptor 2 in Proliferative Verrucous Leukoplakia.
Koh J; Kurago ZB
Head Neck Pathol; 2019 Dec; 13(4):635-642. PubMed ID: 30888638
[TBL] [Abstract][Full Text] [Related]
10. Proliferative verrucous leukoplakia and its related lesions.
Batsakis JG; Suarez P; el-Naggar AK
Oral Oncol; 1999 Jul; 35(4):354-9. PubMed ID: 10645398
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathogenesis of proliferative verrucous leukoplakia: a systematic review.
Okoturo EM; Risk JM; Schache AG; Shaw RJ; Boyd MT
Br J Oral Maxillofac Surg; 2018 Nov; 56(9):780-785. PubMed ID: 30190088
[TBL] [Abstract][Full Text] [Related]
12. Segmentation of Oral Leukoplakia (OL) and Proliferative Verrucous Leukoplakia (PVL) Using Artificial Intelligence Techniques.
Alshawwa SZ; Saleh A; Hasan M; Shah MA
Biomed Res Int; 2022; 2022():2363410. PubMed ID: 35909480
[TBL] [Abstract][Full Text] [Related]
13. Management of proliferative verrucous leukoplakia: Justification for a conservative approach.
Borgna SC; Clarke PT; Schache AG; Lowe D; Ho MW; McCarthy CE; Adair S; Field EA; Field JK; Holt D; Risk JM; Rajlawat BP; Triantafyllou A; Shaw RJ
Head Neck; 2017 Oct; 39(10):1997-2003. PubMed ID: 28640498
[TBL] [Abstract][Full Text] [Related]
14. Single-cell transcriptomics dissects premalignant progression in proliferative verrucous leukoplakia.
Zhong L; Wang F; Liu D; Kuang W; Ji N; Li J; Zeng X; Li T; Dan H; Chen Q
Oral Dis; 2024 Mar; 30(2):172-186. PubMed ID: 35950708
[TBL] [Abstract][Full Text] [Related]
15. Proliferative verrucous leukoplakia: an elusive disorder.
Parashar P
J Evid Based Dent Pract; 2014 Jun; 14 Suppl():147-53.e1. PubMed ID: 24929599
[TBL] [Abstract][Full Text] [Related]
16. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology.
Müller S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):591-602. PubMed ID: 29606637
[TBL] [Abstract][Full Text] [Related]
17. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.
Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH
BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230
[TBL] [Abstract][Full Text] [Related]
18. Proliferative verrucous leukoplakia: recognition and differentiation from conventional leukoplakia and mimics.
Gillenwater AM; Vigneswaran N; Fatani H; Saintigny P; El-Naggar AK
Head Neck; 2014 Nov; 36(11):1662-8. PubMed ID: 24115154
[TBL] [Abstract][Full Text] [Related]
19. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype.
Iocca O; Sollecito TP; Alawi F; Weinstein GS; Newman JG; De Virgilio A; Di Maio P; Spriano G; Pardiñas López S; Shanti RM
Head Neck; 2020 Mar; 42(3):539-555. PubMed ID: 31803979
[TBL] [Abstract][Full Text] [Related]
20. Global gene expression profile of proliferative verrucous leukoplakia and its underlying biological disease mechanisms.
Farah CS; Shearston K; Turner EC; Vacher M; Fox SA
Oral Oncol; 2024 Apr; 151():106737. PubMed ID: 38408418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]